Emma Fixsen is a Dermatology physician affiliated with Duke University. OpenAlex indexes 14 publications with 439 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
77 Vilcom Center Dr Ste 21
Chapel Hill, NC 275141788
Telephone
919-684-3432Provider last certified this registry record 16 Sept 2024.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Galderma Laboratories, L.P.Program year20231 payment
- Novartis Pharmaceuticals CorporationProgram year20231 payment
- Regeneron Healthcare Solutions, Inc.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
26.1%Azole Antifungal13.9%Ketoconazole100%Part D≥24 patientsTetracycline-class Drug7.5%Doxycycline Monohydrate100%Part D≥17 patients+ 1 more class in this area
Dermatology
25.8%Corticosteroid22.3%Triamcinolone Acetonide79%Fluocinolone Acetonide21%Part D<11 patientsAzole Antifungal3.5%Clotrimazole100%Part D<11 patientsSensory organs
21.4%Corticosteroid21.4%Clobetasol Propionate70%Hydrocortisone30%Part D≥32 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Belumosudil: An effective oral steroid‐sparing agent for chronic cutaneous graft‐versus‐host disease
Journal of the European Academy of Dermatology and Venereology
2025 - Inpatient dermatology consultation alters the diagnosis and management of dermatologic diseases in patients living with HIV/AIDS
Archives of Dermatological Research
2024 - LB916 Clinical efficacy of belumosudil in cutaneous chronic graft-versus-host disease
Journal of Investigative Dermatology
2024 - Severe Mpox Infections in People With Uncontrolled Human Immunodeficiency Virus
Clinical Infectious Diseases
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Robert Califf, MD
Duke University
Pamela Douglas, MD
Duke University
Adrian Hernandez, MD
Duke University
John Perfect, MD
Duke University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”